Health Condition 1: M255- Pain in joint
Conditions
Interventions
None listed
Sponsors
Ozone Pharmaceutical Limited
Eligibility
Inclusion criteria
Inclusion criteria: Patients willing to sign the consent form of the clinical trial. Outdoor patients, having chronic pain of musculoskeletal origin (e.g., low backache, knee, shoulder, elbow, wrist, ankle, and neck pain for more than 4 weeks)
Exclusion criteria
Exclusion criteria: History of any trauma/fractured joint/surgical/diagnostic intervention with reference to the affected joint(s), Gross disability in performing daily normal routine, i.e., bed-ridden patients or confined to a wheelchair Patients with co-morbidities such as gouty arthritis, rheumatoid arthritis, and psoriatic arthritis, Patients having any deformity of knee hip or back altering their gait and posture Concomitant use of pain-relieving medications, Patients on prolonged (more than 6 weeks) medication with corticosteroids, antidepressants, anticholinergics, etc., or any other drugs that may have an influence on the outcome of the study, Allergy to Kwik Pain Oil or Tila Taila.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in Visual Analogue Scale (VAS) for Pain, Pain relief period, Duration of pain free periodTimepoint: At baseline, 1st week and 2nd week | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction & Adverse effects.Timepoint: At 1st & 2nd week | — |
Countries
India
Contacts
Public ContactDr Vijay Krishnan
National Institute of Ayurveda, Deemed to be University (De Novo)
Outcome results
None listed